| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 0.647 | 0.423 | 0.14 |
|
disease | 0.400 | None | 0.750 | 4 | 0 | 2005 | 2014 | ||||||||
|
PDZ and LIM domain 5 | 0.525 | 0.808 | 1.7E-03 |
|
disease | 0.380 | None | 0.750 | 4 | 0 | 2004 | 2019 | ||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.400 | None | 1.000 | 4 | 0 | 2004 | 2014 | |||||||||
|
glutamate-ammonia ligase | 0.513 | 0.731 | 1.00 |
|
disease | 0.400 | None | 0.500 | 4 | 0 | 2002 | 2020 | ||||||||
|
G protein subunit beta 1 like | 0.743 | 0.346 | 4.7E-05 |
|
disease | 0.350 | None | 1.000 | 4 | 0 | 2008 | 2012 | ||||||||
|
glutamate ionotropic receptor AMPA type subunit 4 | 0.631 | 0.615 | 1.8E-02 |
|
disease | 0.350 | None | 0.250 | 4 | 0 | 2003 | 2012 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
disease | 0.390 | None | 1.000 | 4 | 0 | 2003 | 2019 | ||||||||
|
sigma non-opioid intracellular receptor 1 | 0.544 | 0.808 | 0.17 |
|
disease | 0.360 | None | 0.500 | 4 | 0 | 2000 | 2017 | ||||||||
|
proteolipid protein 1 | 0.543 | 0.769 | 0.93 |
|
disease | 0.350 | None | 0.750 | 4 | 0 | 2004 | 2010 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 4 | 0.678 | 0.423 | 0.11 |
|
disease | 0.350 | None | 0.500 | 4 | 0 | 2006 | 2018 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2C | 0.792 | 0.269 | 2.3E-07 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2003 | 2014 | ||||||||
|
cholinergic receptor muscarinic 1 | 0.653 | 0.577 | 0.99 |
|
disease | 0.400 | None | 0.500 | 4 | 0 | 2002 | 2019 | ||||||||
|
homer scaffold protein 1 | 0.636 | 0.538 | 1.00 |
|
disease | 0.400 | None | 1.000 | 4 | 0 | 2003 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.550 | None | 0.500 | 4 | 0 | 2004 | 2012 | ||||||||
|
cholinergic receptor nicotinic alpha 7 subunit | 0.532 | 0.654 | 4.2E-04 |
|
disease | 0.700 | None | 0.750 | 4 | 0 | 1998 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit gamma2 | 0.548 | 0.654 | 0.74 |
|
disease | 0.340 | None | 0.500 | 4 | 0 | 2005 | 2014 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.460 | None | 1.000 | 4 | 0 | 2009 | 2019 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
disease | 0.400 | None | 0.750 | 4 | 0 | 2001 | 2019 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 4 | 0 | 1999 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.470 | None | 0.500 | 4 | 0 | 2002 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha1 | 0.563 | 0.577 | 0.91 |
|
disease | 0.350 | None | 0.500 | 4 | 0 | 2005 | 2017 | ||||||||
|
neurotensin | 0.517 | 0.769 | 3.9E-05 |
|
disease | 0.370 | None | 1.000 | 4 | 0 | 1999 | 2019 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.340 | None | 0.750 | 4 | 0 | 2010 | 2017 | ||||||||
|
ciliary neurotrophic factor | 0.561 | 0.615 | 2.3E-05 |
|
disease | 0.390 | None | 0.250 | 4 | 0 | 1996 | 2008 | ||||||||
|
sulfotransferase family 4A member 1 | 0.700 | 0.346 | 0.97 |
|
disease | 0.350 | None | 0.750 | 4 | 0 | 2005 | 2014 |